Search

Your search keyword '"Agmon-Levin, N."' showing total 95 results

Search Constraints

Start Over You searched for: Author "Agmon-Levin, N." Remove constraint Author: "Agmon-Levin, N." Search Limiters Full Text Remove constraint Search Limiters: Full Text
95 results on '"Agmon-Levin, N."'

Search Results

1. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials

2. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

4. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic

5. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

6. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

7. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

8. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

9. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

10. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

11. Gastrointestinal-associated autoantibodies in different autoimmune diseases

12. From ANA-screening to antigen-specificity : an EASI-survey on the daily practice in European countries

13. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

14. Human papillomavirus vaccine and systemic lupus erythematosus

16. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells.

17. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic

18. The hyperferritinemic syndromes and CD163: a marker of macrophage activation

19. Prevalence of hepatitis C serum antibody in autoimmune diseases

20. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

21. Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases

22. Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease-a prospective pilot study.

23. Peanut allergen characterization and allergenicity throughout development.

24. Drug fever-an immune-mediated delayed type hypersensitivity reaction to Vinca alkaloids in pediatric oncology patients, possibly mediated by cysteinyl leukotrienes.

25. Idiopathic Eosinophilic Vasculitis: A Case Series.

26. Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels.

27. Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease.

28. Nsaids Linked to IgA-Mediated Hypersensitivity Vasculitis and Purpura Fulminans-Like Eruption.

29. Smell Function in Schizophrenia During Acute Psychosis and Correlation with Clinical Symptomatology and Length of Hospitalization.

30. Heart Valve Surgery in Antiphospholipid Syndrome Patients-Morbidity and Mortality.

31. A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.

32. Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid.

33. A clinical pathway for the diagnosis of sesame allergy in children.

34. Ethnicity and Antiphospholipid Syndrome in Israel.

35. Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus.

36. A Multidisciplinary Thyroid Eye Clinic: A One-stop Shop.

37. Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still's Disease.

38. Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine.

39. Autoimmune Neutropenia Associated With HHV-6 Virus Infection: A Case Report.

40. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome.

41. Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up.

42. Diagnosis of Peanut Allergy in Preschool Children: The Impact of Skin Testing With a Novel Composition of Peanuts.

43. Mindfulness-Based Stress Reduction for Systemic Lupus Erythematosus: A Mixed-Methods Pilot Randomized Controlled Trial of an Adapted Protocol.

44. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.

45. Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency

46. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.

47. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.

48. Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experience.

49. Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome.

50. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H 1 -Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study.

Catalog

Books, media, physical & digital resources